Ikarian Capital »

Neuronetics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Neuronetics (STIM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Neuronetics

Tip: Access up to 7 years of quarterly data

All positions including Neuronetics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuronetics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 906k 2.73
2025-06-30 $3.8M 1.1M 3.49
2025-03-31 $4.0M 1.1M 3.68

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Neuronetics

Balyasny Asset Management
Vanguard Group
BlackRock
UBS Group
Wexford Capital
Masters Capital Mgmt
Marshall Wace
Ikarian Capital
Geode Capital Management
Morgan Stanley
State Street Corporation
HighTower Advisors
FourWorld Capital Management
Millennium Management
Two Sigma Investments

View all funds holding Neuronetics